Page results
-
This page provides information about ERCP (Endoscopic Retrograde Cholangiopancreatography) procedure.
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
-
Latest news and developments in the Macmillan Support and Information Service
-
Information about staff who work in the Macmillan Support and Information Service.
-
Advice on socialising and managing friendships for young people living with fatigue conditions.
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
File results
-
FOI/2023/0831 - Treatments for acute myeloid leukaemia/ chronic lymphocytic leukaemia
-
FOI/2023/0832 - Hospital admissions for vaping related disorders
-
FOI/2023/0833 - Evaluation of outpatient referrals to neurosurgical department
-
FOI/2023/0836 - Translation services and technologies
-
FOI/2023/0837 - Treatment for Myelofibrosis
-
FOI/2023/0840 - Deaths in accident and emergency 2018-2023
-
FOI/2023/0842 - Acquired Brain Injury condition daily fees/ spend per patient
-
FOI/2023/0845 - Treatement for gastric and gastro-oesophageal junction/ Oesophageal/ ovarian cancers
-
FOI/2023/0849 - Physician Associates
-
FOI/2023/0870 - Cancer treatments cancelled or rescheduled